A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract von Graham, J S, Boyd, K, Coxon, F Y, Wall, L R, Eatock, M M, Maughan, T S, Highley, M, Soulis, E, Harden, S, Bützberger-Zimmerli, P, Evans, T R J

Volltext

Preliminary safety data from a randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or without bevacizumab (B) in patients (pts) with gastric or oes... von Okines, A. F., Langley, R., Cafferty, F. H., Stenning, S. P., Falk, S., Seymour, M. T., Smith, D., Middleton, G. W., Coxon, F. Y., Cunningham, D.

Volltext

Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with ad... von Neoptolemos, J. P., Moore, M. J., Cox, T. F., Valle, J. W., Palmer, D. H., Mcdonald, A., Carter, R., Tebbutt, N. C., Dervenis, C., Smith, D., Glimelius, B., Coxon, F. Y., Lacaine, F., Middleton, M. R., Ghaneh, P., Bassi, C., Halloran, C., Olah, A., Rawcliffe, C. L., Büchler, M. W.

Volltext

REAL3: A multicenter randomized phase II/III trial of epirubicin, oxaliplatin, and capecitabine (EOC) versus modified (m) EOC plus panitumumab (P) in advanced oesophagogastric (OG)... von Chau, I., Okines, A. F. C., Gonzalez de Castro, D., Saffery, C., Barbachano, Y., Wotherspoon, A., Puckey, L., Hulkki Wilson, S., Coxon, F. Y., Middleton, G. W., Ferry, D. R., Crosby, T. D. L., Madhusudan, S., Wadsley, J., Waters, J. S., Hall, M., Swinson, D., Robinson, A., Smith, D., Cunningham, D.

Volltext

Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with ad... von Neoptolemos, J. P., Moore, M. J., Cox, T. F., Valle, J. W., Palmer, D. H., Mcdonald, A., Carter, R., Tebbutt, N. C., Dervenis, C., Smith, D., Glimelius, B., Coxon, F. Y., Lacaine, F., Middleton, M. R., Ghaneh, P., Bassi, C., Halloran, C., Olah, A., Rawcliffe, C. L., Büchler, M. W.

Volltext

Safety results from a randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or without bevacizumab (B) in patients (pts) with gastric or type II/III... von Okines, A. F. C., Langley, R. E., Thompson, L. C., Stenning, S. P., Stevenson, L., Falk, S., Seymour, M. T., Coxon, F. Y., Middleton, G. W., Smith, D., Evans, L., Slater, S., Waters, J. S., Ford, D., Hall, M., Iveson, T., Petty, R. D., Plummer, C., Allum, W., Cunningham, D.

Volltext

Can Patients With Relapsed, Previously Untreated, Stage I Epithelial Ovarian Cancer Be Successfully Treated With Salvage Therapy? von KOLOMAINEN, Desiree F, A'HERN, Roger, COXON, Fareeda Y, FISHER, Cyril, KING, D. Michael, BLAKE, Peter R, BARTON, Desmond P. J, SHEPHERD, John H, KAYE, Stanley B, GORE, Martin E

Volltext

Safety of capecitabine (X) compared to fluorouracil/leucovorin (5-FU/LV) for the adjuvant treatment of elderly colon cancer patients (pts) von Díaz-Rubio, E., Burris, H., Douillard, J. Y., Coxon, F. Y., Maughan, T., Bertetto, O., Schueller, J., Husseini, F., Marschner, N., Scheithauer, W.

Volltext

Safety of capecitabine (X) compared to fluorouracil/leucovorin (5-FU/LV) for the adjuvant treatment of elderly colon cancer patients (pts) von Díaz-Rubio, E., Burris, H., Douillard, J. Y., Coxon, F. Y., Maughan, T., Bertetto, O., Schueller, J., Husseini, F., Marschner, N., Scheithauer, W.

Volltext

The place of polymer prodrugs in cancer therapy von Coxon, Fareeda Y, Cassidy, James

Volltext

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, o... von Cunningham, D, Stenning, SP, Smyth, EC, Okines, AF, Allum, WH, Rowley, S, Stevenson, L, Grabsch, HI, Alderson, D, Crosby, T, Griffin, SM, Mansoor, W, Coxon, FY, Falk, SJ, Darby, S, Sumpter, KA, Blazeby, JM, Langley, RE

Volltext bestellen

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, o... von Cunningham, D, Stenning, SP, Smyth, EC, Okines, AF, Allum, WH, Rowley, S, Stevenson, L, Grabsch, HI, Alderson, D, Crosby, T, Griffin, SM, Mansoor, W, Coxon, FY, Falk, SJ, Darby, S, Sumpter, KA, Blazeby, JM, Langley, RE

Volltext bestellen

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, o... von Cunningham, David, Prof, Stenning, Sally P, Prof, Smyth, Elizabeth C, MBBCh, Okines, Alicia F, MD, Allum, William H, MD, Rowley, Sam, MSc, Stevenson, Laura, MSc, Grabsch, Heike I, Prof, Alderson, Derek, Prof, Crosby, Thomas, FRCR, Griffin, S Michael, Prof, Mansoor, Wasat, PhD, Coxon, Fareeda Y, MBBS, Falk, Stephen J, MD, Darby, Suzanne, MBChB, Sumpter, Kate A, MD, Blazeby, Jane M, Prof, Langley, Ruth E, Prof

Volltext

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study von Primrose, John N, Fox, Richard P, Palmer, Daniel H, Malik, Hassan Z, Prasad, Raj, Mirza, Darius, Anthony, Alan, Corrie, Pippa, Falk, Stephen, Finch-Jones, Meg, Wasan, Harpreet, Ross, Paul, Wall, Lucy, Wadsley, Jonathan, Evans, Jeff T R, Stocken, Deborah, Praseedom, Raaj, Ma, Yuk Ting, Davidson, Brian, Neoptolemos, John P, Iveson, Tim, Raftery, James, Zhu, Shihua, Cunningham, David, Garden, O James, Stubbs, Clive, Valle, Juan W, Bridgewater, John, Primrose, JN, Fox, RP, Morement, H, Chan, O, Rees, C, Ma, YT, Hickish, T, Falk, S, Finch-Jones, M, Pope, I, Corrie, P, Crosby, T, Sothi, S, Sharkland, K, Adamson, D, Wall, L, Evans, J, Dent, J, Hombaiah, U, Iwuji, C, Anthoney, A, Bridgewater, J, Cunningham, D, Gillmore, R, Ross, P, Slater, S, Wasan, H, Waters, J, Valle, JW, Palmer, D, Malik, H, Neoptolemos, J, Faluyi, O, Sumpter, K, Dernedde, U, Maduhusudan, S, Cogill, G, Archer, C, Iveson, T, Wadsley, J, Darby, S, Peterson, M, Mukhtar, AA, Thorpe, JG, Bateman, A, Tsang, D, Cummins, S, Nolan, L, Beaumont, E, Prasad, R, Mirza, D, Stocken, D, Praseedom, R, Davidson, B, Raftery, J, Zhu, S, Garden, J, Stubbs, C, Coxon, F

Volltext

Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation von Komiya, T, Park, Y, Modi, S, Coxon, A B, Oh, H, Kaye, F J

Volltext

Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer von Komiya, T, Coxon, A, Park, Y, Chen, W-D, Zajac-Kaye, M, Meltzer, P, Karpova, T, Kaye, F J

Volltext

Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes von COXON, Amy, ROZENBLUM, Ester, PARK, Yoon-Soo, JOSHI, Nina, TSURUTANI, Junji, DENNIS, Phillip A, KIRSCH, Ilan R, KAYE, Frederic J

Volltext

Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2 von Oliner, Jonathan, Min, Hosung, Leal, Juan, Yu, Dongyin, Rao, Shashirekha, You, Edward, Tang, Xiu, Kim, Haejin, Meyer, Susanne, Han, Seog Joon, Hawkins, Nessa, Rosenfeld, Robert, Davy, Elyse, Graham, Kevin, Jacobsen, Frederick, Stevenson, Shirley, Ho, Joanne, Chen, Qing, Hartmann, Thomas, Michaels, Mark, Kelley, Michael, Li, Luke, Sitney, Karen, Martin, Frank, Sun, Ji-Rong, Zhang, Nancy, Lu, John, Estrada, Juan, Kumar, Rakesh, Coxon, Angela, Kaufman, Stephen, Pretorius, James, Scully, Sheila, Cattley, Russ, Payton, Marc, Coats, Steve, Nguyen, Linh, Desilva, Binodh, Ndifor, Anthony, Hayward, Isaac, Radinsky, Robert, Boone, Tom, Kendall, Richard

Volltext

Biomarker analysis in oesophagogastric cancer: Results from the REAL3 and TransMAGIC trials von Okines, A.F.C, Gonzalez de Castro, D, Cunningham, D, Chau, I, Langley, R.E, Thompson, L.C, Stenning, S.P, Saffery, C, Barbachano, Y, Coxon, F, Middleton, G, Ferry, D, Crosby, T, Madhusudan, S, Wadsley, J, Waters, J, Hall, M, Swinson, D, Robinson, A, Smith, D, Reis-Filho, J.S, Waddell, T.S, Puckey, L, Hulkki Wilson, S, Eltahir, Z, Band, M, Wotherspoon, A

Volltext

The challenge of unprecedented floods and droughts in risk management von Kreibich, H, Van Loon, AF, Schroeter, K, Ward, PJ, Mazzoleni, M, Sairam, N, Abeshu, GW, Agafonova, S, AghaKouchak, A, Aksoy, H, Alvarez-Garreton, C, Aznar, B, Balkhi, L, Barendrecht, MH, Biancamaria, S, Bos-Burgering, L, Bradley, C, Budiyono, Y, Buytaert, W, Capewell, L, Carlson, H, Cavus, Y, Couasnon, A, Coxon, G, Daliakopoulos, I, De Ruiter, MC, Delus, C, Erfurt, M, Esposito, G, Francois, D, Frappart, F, Freer, J, Frolova, N, Gain, AK, Grillakis, M, Grima, JO, Guzman, DA, Huning, LS, Ionita, M, Kharlamov, M, Khoi, DN, Kieboom, N, Kireeva, M, Koutroulis, A, Lavado-Casimiro, W, Li, H-Y, LLasat, MC, Macdonald, D, Mard, J, Mathew-Richards, H, McKenzie, A, Mejia, A, Mendiondo, EM, Mens, M, Mobini, S, Mohor, GS, Nagavciuc, V, Thanh, N-D, Thi, TNH, Pham, TTN, Petrucci, O, Hong, QN, Quintana-Segui, P, Razavi, S, Ridolfi, E, Riegel, J, Sadik, MS, Savelli, E, Sazonov, A, Sharma, S, Sorensen, J, Souza, FAA, Stahl, K, Steinhausen, M, Stoelzle, M, Szalinska, W, Tang, Q, Tian, F, Tokarczyk, T, Tovar, C, Tran, TVT, Van Huijgevoort, MHJ, Van Vliet, MTH, Vorogushyn, S, Wagener, T, Wang, Y, Wendt, DE, Wickham, E, Yang, L, Zambrano-Bigiarini, M, Bloschl, G, Di Baldassarre, G

Volltext